Altus Pharmaceuticals news from FierceBiotech
NewsAltus shares nosedive despite Phase III success
Hitting a primary endpoint in a late-stage trial is not always a recipe for success, it seems. Shares of Altus Pharmaceuticals nosedived this morning after the company issued a release saying that Read more...
C&L: Somnus names executive team
Gary Cupit, PharmD, has been named CEO of Somnus Therapeutics. The rest of the executive team: Mary Osbakken, MD, PhD, chief medical officer; Christine Blumhardt, PharmD, chief regulatory officer; Read more...
SPOTLIGHT: Altus hires new CEO
Altus Pharmaceuticals has hired Georges Gemayel from Genzyme to be its new CEO. Gemayel had been executive vice president at Genzyme. Both companies are based in Cambridge. Read more...
Developers seek alternatives to animal ingredients
The brouhaha over heparin has cast a spotlight on the use of animal products in therapies. It also Read more...
ALSO NOTED: GTC announces positive ATryn data; NC biotech center to expand; FDA delays Requip XL decision; and much more...
> Shares of GTC Biotherapeutics were buoyed after the company announced positive results from a late-stage study of ATryn among patients with hereditary antithrombin deficiency undergoing Read more...
Altus shares dive as Genentech hands back drug rights
Shares of Altus Pharmaceuticals took a dive this morning after the biotech announced that it had reacquired the North American rights to a growth hormone program from Genentech. Altus immediately Read more...
| Press ReleasesPRESS RELEASE: Altus Pharmaceuticals Reacquires ALTU-238 Global Development and Commercialzation Rights Altus Pharmaceuticals Reacquires ALTU-238 Global Development and Commercialzation Rights CAMBRIDGE, Mass. -- Altus Pharmaceuticals announced today that it has reacquired ALTU-238 development and Read more... |
Get more Altus Pharmaceuticals coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets